About Dharoya Pharmaceuticals
Dharoya Pharmaceuticals is a Healthcare company based in Vadodara (India) founded in 1985. It produces high-quality API intermediates, specializing in anti-epileptic and anti-depressant products. It operates on a B2B model. Its Indian entity Dharoya Pharmaciuticales Pvt Ltd reported revenue of ₹6.93 Cr. Its focus areas include Pharmaceuticals, API Manufacturing and Drug Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Dharoya Pharmaceuticals produces high-quality api intermediates, specializing in anti-epileptic and anti-depressant products through providing healthcare solutions, producing pharmaceutical products, api manufacturing, and drug intermediates. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Vadodara, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dharoyapharma.com
- Legal Name Dharoya Pharmaciuticales Pvt Ltd
- Date of Incorporation 25 Nov, 1988
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹6.93 Cr
FY 2025 · -29% YoY
- Net Profit₹13.9 Lakh
FY 2025 · 2% margin
- EBITDA₹52.6 Lakh
FY 2025 · 8% margin
Associated legal entities of Dharoya Pharmaceuticals
Dharoya Pharmaceuticals operates through Dharoya Pharmaciuticales Pvt Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dharoya Pharmaciuticales Pvt Ltd CIN U24231GJ1988PTC011555 | Active | 25 Nov 1988 | Vadodara, Gujarat | ₹6.9 Cr | 2 | View details |
Board of directors of Dharoya Pharmaciuticales Pvt Ltd (Dharoya Pharmaceuticals)
Dharoya Pharmaciuticales Pvt Ltd is the primary company behind Dharoya Pharmaceuticals. The board of Dharoya Pharmaciuticales Pvt Ltd currently have 2 directors; the longest-serving is Kishan Gordhanbhai Rupapara, appointed in 2017. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kishan Gordhanbhai Rupapara DIN 07919139 | Director | 01 Aug 2017 | 9 yrs 3 mo | Dharoya Pharmaciuticales Pvt Ltd |
| Bhavnaben Gordhanbhai Rupapara DIN 05245844 | Director | 01 Aug 2017 | 9 yrs 3 mo | Dharoya Pharmaciuticales Pvt Ltd |
Financials of Dharoya Pharmaceuticals
Figures of Dharoya Pharmaciuticales Pvt Ltd, the primary company behind Dharoya Pharmaceuticals, for FY 2025. Revenue was ₹6.93 Cr (-29% year on year). Net profit was ₹13.9 Lakh (2% margin). EBITDA was ₹52.6 Lakh (8% margin). Revenue has grown at a compounded annual rate of +17% over three years and +47% over five years.
- ₹6.93 CrRevenue · FY 2025 · -29% YoY
- ₹13.9 LakhNet profit · 2% margin
- ₹52.6 LakhEBITDA · 8% margin
- ₹4 LakhPaid-up capital
- +17%Revenue CAGR, 3 years
- +47%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Dharoya Pharmaciuticales Pvt Ltd are on its company page.
Detailed financial statements for Dharoya Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Dharoya Pharmaceuticals
Dharoya Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Dharoya Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dharoya Pharmaceuticals
Dharoya Pharmaceuticals was founded in 1985.
Dharoya Pharmaceuticals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
The primary company behind Dharoya Pharmaceuticals, Dharoya Pharmaciuticales Pvt Ltd, reported revenue of ₹6.93 Cr for FY 2025, down 29% year on year.
Dharoya Pharmaceuticals produces high-quality api intermediates, specializing in anti-epileptic and anti-depressant products through providing healthcare solutions, producing pharmaceutical products, api manufacturing, and drug intermediates. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Dharoya Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Dharoya Pharmaceuticals operates through Dharoya Pharmaciuticales Pvt Ltd.
The legal entities of Dharoya Pharmaceuticals currently have 2 directors, including Kishan Gordhanbhai Rupapara, Bhavnaben Gordhanbhai Rupapara.